Meng Lv

Meng Lv


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2015 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
MLMeng Lv
Meng Lv
XWXuetao Wang
Xuetao Wang
WQWendong Qu
Wendong Qu
MLMengjie Liu
Mengjie Liu
YWYuelan Wang
Yuelan Wang
Shivering is a frequent complication following surgery and anaesthesia. A large variety of studies have been reported that nefopam may be efficacious for the prevention and treatment of perioperative shivering. Regrettably, there is still no conclusion of the efficacy and safety of nefopam for the prevention of perioperative shivering. The aim of this analysis is to evaluate the efficacy of nefopam for the prevention of perioperative shivering in patients undergoing different types of anaesthesia compared with placebo group and other active interventions. PubMed, EMBASE, Cochrane Central Register of Control Trials were systematically searched for potentially relevant trials. Trial quality and extracted data were evaluated by two authors independently. Dichotomous data on the absence of shivering was extracted and analysed by using relative risk (RR) with 95 % confidence interval (CI). Continuous outcome was abstracted and analysed by using weighted mean difference (WMD) with 95 % confidence interval (CI). Outcome data was analysed by using random effect model or fixed effect model in accordance with heterogeneity. Compared with placebo, prophylactic administration of nefopam significantly reduced the risk of perioperative shivering not only in the patients under general anaesthesia but also neuraxial anaesthesia (RR 0.08; 95 % CI 0.05-0.13). As compared with clonidine, nefopam was more efficacious in the prevention of perioperative shivering (RR 0.34; 95 % CI 0.17-0.70). Nefopam has no influence on the extubation time (WMD 0.92; 95 % CI −0.15-1.99). Our analysis has demonstrated that nefopam is associated with the decrease of risk of perioperative shivering following anaesthesia without influencing the extubation time.

25 April 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
CQChanglong Qiao
Changlong Qiao
JZJing Zhou
Jing Zhou
CWChuansong Wei
Chuansong Wei
JCJing Cao
Jing Cao
KZKe Zheng
Ke Zheng
MLMeng Lv
Meng Lv
Background: Cardiac surgery-associated acute kidney injury (CSA-AKI) significantly increases postoperative mortality and healthcare costs. Despite the growing volume of CSA-AKI research, the field remains fragmented, with challenges in identifying high-impact studies, collaborative networks, and emerging trends. Bibliometric analysis addresses these gaps by systematically mapping knowledge structures, revealing research priorities, and guiding resource allocation for both researchers and clinicians.Method: We analyzed 4,474 CSA-AKI-related publications (2014–2023) from the Web of Science Core Collection (WoSCC) using VOSviewer, CiteSpace, the Bibliometrix Package in R, and the bibliometric online analysis platform.Results: Annual publications increased steadily, with the USA and China leading productivity. The Journal of Cardiothoracic and Vascular Anesthesia serves as the foremost preferred journal within this domain. Critical Care (IF = 15.1) has the highest impact factor. Yunjie Li published the most papers. John A Kellum has the highest H-index. The definition, pathogenesis or etiology, diagnosis, prediction, prevention and treatment, which are the research basis in CSA-AKI. Machine learning (ML) and prediction models emerged as dominant frontiers (2021–2023), reflecting a shift toward personalized risk stratification and real-time perioperative decision-making. These advancements align with clinical demands for early AKI detection and precision prevention.Conclusion: This study not only maps the evolution of CSA-AKI research but also identifies priority areas for innovation: multicenter validation of predictive models to strengthen generalizability, preventive nephrology frameworks for long-term AKI survivor monitoring, and randomized controlled trials to confirm efficacy of machine learning-based CSA-AKI prediction tools.

11 February 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
CCCuicui Cao
Cuicui Cao
MLMeng Lv
Meng Lv
CWChuansong Wei
Chuansong Wei
JYJie Yan
Jie Yan
YWYuelan Wang
Yuelan Wang
CGchangping Gu
changping Gu
Introduction Shivering is a common complication in the postoperative period. The incidence of shivering has been reported to range from 5% to 65% under general anaesthesia and as 33% during epidural anaesthesia. Shivering can increase perioperative risk in patients. Both dexmedetomidine and meperidine are effective agents for the prevention of postanaesthetic shivering. However, few studies have compared the anti-shivering effects of different agents following coronary artery bypass graft (CABG). This study aims to compare the effects of dexmedetomidine and meperidine on the incidence of shivering in patients undergoing CABG. Methods and analysis A total of 180 patients aged 18–75 years, with an American Society of Anesthesiologists (ASA) grade of II–IV, undergoing elective CABG will be enrolled and randomly assigned to the dexmedetomidine, meperidine and control groups (placebo) in an intended 1:1:1 allocation ratio. The patients will be followed up for 7 days after surgery. The primary outcome is the incidence of shivering within 24 hours postoperatively. The secondary outcomes are the number of remedial drugs used after surgery, the incidence of postoperative hypotension and bradycardia, sedation scores, endotracheal extubation time, intensive care unit length of stay, incidence of postoperative delirium within 7 days after surgery, incidence of postoperative arrhythmias, incidence of postoperative nausea and vomiting, average hospital length of stay and mortality rate 30 days after surgery. Ethics and dissemination The study protocol was approved by the ethics committee of The First Affiliated Hospital of Shandong First Medical University on 20 January 2021 (YXLL-KY-2021(002)) and registered at ClinicalTrials.gov. The results of this study will be presented at national and international scientific meetings and conferences. We plan to publish the data in peer-reviewed international scientific journals. Trial registration number NCT04735965.

10 October 2025 in Medicine
Verified
Journal Article
Open access
PZPeipei Zhang
Peipei Zhang
XZXuping Zhang
Xuping Zhang
KZKe Zheng
Ke Zheng
LHLonghai He
Longhai He
MLMeng Lv
Meng Lv
Stress hyperglycemia ratio (SHR) is established as a predictor of adverse outcomes among patients with cardiovascular and cerebrovascular diseases. However, its relationship with prognosis in patients undergoing coronary artery bypass grafting (CABG) for acute myocardial infarction (AMI) remains inconclusive. This study aimed to explore the association of SHR with short-term mortality among this specific patient population. A retrospective cohort study was conducted by analyzing data from 1006 patients who underwent CABG for AMI, extracted from the Medical Information Mart for Intensive Care IV (version 3.1) database. Patients were stratified into tertiles according to SHR levels. Cox proportional hazards models, including a segmented version, were applied to evaluate the relationship between SHR and mortality at both 90 and 180 days. Within the study population, 47 patients (4.67%) died within 90 days, and 60 patients (5.96%) within 180 days. After adjustment for multiple covariates, patients in the highest SHR tertile exhibited a substantially higher mortality risk at 90 and 180 days compared to those in the lowest tertile (T3 vs T1: hazard ratio 3.78–4.19, P < .001 for both, trend P < .001). Our findings indicate that elevated SHR, measured by the glucose/hemoglobin A1c ratio, is associated with higher short-term mortality in patients undergoing CABG for AMI. The restricted cubic spline model showed that all-cause mortality at 90 and 180 days was positively associated with SHR levels.

4 August 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
BLBinghua Liu
Binghua Liu
MLMeng Lv
Meng Lv
HWHaiyan Wang
Haiyan Wang
YSYongtao Sun
Yongtao Sun
XSXiumei Song
Xiumei Song
YWYuelan Wang
Yuelan Wang
Introduction Previous studies on transoesophageal echocardiography in coronary artery bypass grafting mainly focused on whether to change the surgical plan rather than improve the clinical prognosis. Currently, there are sparse studies on the relationship between transoesophageal echocardiography indicators and the prognosis of patients undergoing coronary artery bypass grafting. The primary aim of this study is to explore the association between transoesophageal echocardiography monitoring indicators the respiratory variability of inferior vena cava diameter, tricuspid annular plane systolic excursion and the incidence of acute kidney injury in coronary artery bypass grafting patients. Methods and analysis We designed this prospective multicenter cohort study, which included approximately 150 adult patients (≥18 years) undergoing elective coronary artery bypass surgery. Different hospitals will be assessed to obtain information on the prevalence, risk factors, management strategies and outcomes in coronary artery bypass surgery. The cohort will be followed after the coronary artery bypass surgery period, up to 30 days after enrolment. The incidence of postoperative acute kidney injury and baseline data will be presented by descriptive statistics. We will use Freidman inspection and multivariable logistic regression to assess the association between transoesophageal echocardiography monitoring indicators and the incidence of acute kidney injury in coronary artery bypass grafting patients. Ethics and dissemination The study has been approved by the ethics committee of Shandong Provincial Qianfoshan Hospital, China (approval number: YXLL-KY-2021(067)). This is an observational study that poses no risk to the patients. All participants will obtain informed consent according to the ethics committee before patient enrolment. Funding sources will have no influence on data handling, analyses or writing of the manuscript. The article is planned for submission in an international peer-reviewed journal. Trial registration number NCT05139108.

30 August 2022 in Trials
Verified
Journal Article
Open access
PDF file
JWJi-Hua Wang
Ji-Hua Wang
MLMeng Lv
Meng Lv
HZHai-Xia Zhang
Hai-Xia Zhang
YGYang Gao
Yang Gao
TCTing-Ting Chen
Ting-Ting Chen
YWYuelan Wang
Yuelan Wang
Background: Postoperative delirium in elderly patients is a common and costly complication after surgery. Propofol and sevoflurane are commonly used anesthetics during general anesthesia, and the sedative and anti-inflammatory mechanisms of the two medications are different. The aim of this trial is to compare the impact of propofol with sevoflurane on the incidence of postoperative delirium in elderly patients after spine surgery. Methods: A single-center randomized controlled trial will be performed at First Affiliated Hospital of Shandong First Medical University, China. A total of 298 participants will be enrolled in the study and randomized to propofol infusion or sevoflurane inhalation groups. The primary outcome is the incidence of delirium within 7 days after surgery. Secondary outcomes include the day of postoperative delirium onset, duration (time from first to last delirium-positive day), and total delirium-positive days among patients who developed delirium; tracheal intubation time in PACU; the length of stay in PACU; the rate of postoperative shivering; the rate of postoperative nausea and vomiting; the rate of emergence agitation; pain severity; QoR40 at the first day after surgery; the length of stay in hospital after surgery; and the incidence of non-delirium complications within 30 days after surgery. Discussion: The primary objective of this study is to compare the impact of propofol and sevoflurane on the incidence of postoperative delirium for elderly patients undergoing spine surgery. The results may help inform strategies to the optimal selection of maintenance drugs for general anesthesia in elderly patients undergoing spine surgery. Trial registration: ClinicalTrials.gov NCT05158998. Registered on 14 December 2021